Fundraising Fox
Mark R. Bamforth
InvestorExecutive Advisor at Ampersand
Find your path to Mark
38 people in our graph can introduce you to Mark.
Sign up to see every warm intro you have to Mark
- Paths you didn't know you had: your email and LinkedIn already hold routes to Mark. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Mark R. Bamforth joined Ampersand as an Operating Partner in 2018 and became an Executive Advisor in 2023. He founded several contract development and manufacturing organizations, including Brammer Bio (cell and gene therapy, sold to Thermo Fisher Scientific in 2019), Arranta Bio (mRNA, sold to Recipharm), and Gallus BioPharmaceuticals (sold to DPx Holdings/Patheon in 2014), and earlier spent 22 years at Genzyme Corp. running global operations and its pharmaceutical CMO business. He holds a B.S. in Chemical Engineering from Strathclyde University and an M.B.A. from Henley Management College.
Invests in
Biotech
Investments
Board seats
Arranta BioCONTINUUS PharmaceuticalsEnteroBiotixKincell BioPneumagen Limited
Investor
Brammer Bio
Per the firm's website.
Colleagues at Ampersand
Frequently asked questions
- Who is Mark R. Bamforth?
- Mark R. Bamforth joined Ampersand as an Operating Partner in 2018 and became an Executive Advisor in 2023. He founded several contract development and manufacturing organizations, including Brammer Bio (cell and gene therapy, sold to Thermo Fisher Scientific in 2019), Arranta Bio (mRNA, sold to Recipharm), and Gallus BioPharmaceuticals (sold to DPx Holdings/Patheon in 2014), and earlier spent 22 years at Genzyme Corp. running global operations and its pharmaceutical CMO business. He holds a B.S. in Chemical Engineering from Strathclyde University and an M.B.A. from Henley Management College.
- Where does Mark R. Bamforth work?
- Mark R. Bamforth is Executive Advisor at Ampersand.
- What does Mark R. Bamforth invest in?
- Mark R. Bamforth invests in Biotech.
- What boards does Mark R. Bamforth sit on?
- Mark R. Bamforth holds tracked board seats at Arranta Bio, CONTINUUS Pharmaceuticals, EnteroBiotix, Kincell Bio, Pneumagen Limited.
- What companies has Mark R. Bamforth invested in?
- Investments tracked here include Brammer Bio.